Literature DB >> 3919571

Aplastic anemia occurring as amegakaryocytic thrombocytopenia with and without an inhibitor of granulopoiesis.

L M Slater, J Katz, B Walter, S A Armentrout.   

Abstract

Two patients with aplastic anemia evolving from cellular bone marrows with severely diminished megakaryocytes are reported. During this evolution a plasma inhibitor of in vitro granulocyte-macrophage colony formation was demonstrated associated with non-A, non-B hepatitis in one patient. The second patient had abnormal liver function that corrected after the delivery of a normal newborn but there was persistence of pancytopenia without evidence of a plasma inhibitor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919571     DOI: 10.1002/ajh.2830180305

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Therapeutic effect of cyclosporine A in thrombocytopenia after myeloablative chemotherapy in acute myeloid leukaemia.

Authors:  Y Novik; L Oleksowicz; P H Wiernik
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

2.  Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case Report.

Authors:  Arya Mariam Roy; Manojna Konda; George K Sidarous; Dinesh Atwal; Steven A Schichman; Anuradha Kunthur
Journal:  Perm J       Date:  2020-12

3.  Immune-mediated thrombocytopenia induced with durvalumab after chemoradiotherapy in a non-small cell lung cancer patient: A case report.

Authors:  Tomonori Makiguchi; Hisashi Tanaka; Kosuke Kamata; Kageaki Taima; Akira Kurose; Sadatomo Tasaka
Journal:  Thorac Cancer       Date:  2021-08-17       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.